Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RMGI vs Resin Infiltration for White Spot Lesions
NCT02912741Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Jan 2017
- Primary completion
- Jan 2018
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Cairo University. Primary endpoint: Change in Patient satisfaction at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT02912741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912741.